242 related articles for article (PubMed ID: 32480216)
1. Polydatin for treating atherosclerotic diseases: A functional and mechanistic overview.
Wu M; Li X; Wang S; Yang S; Zhao R; Xing Y; Liu L
Biomed Pharmacother; 2020 Aug; 128():110308. PubMed ID: 32480216
[TBL] [Abstract][Full Text] [Related]
2. Insights into pharmacological mechanisms of polydatin in targeting risk factors-mediated atherosclerosis.
Ahmad P; Alvi SS; Iqbal D; Khan MS
Life Sci; 2020 Aug; 254():117756. PubMed ID: 32389832
[TBL] [Abstract][Full Text] [Related]
3. Polydatin prevents fructose-induced liver inflammation and lipid deposition through increasing miR-200a to regulate Keap1/Nrf2 pathway.
Zhao XJ; Yu HW; Yang YZ; Wu WY; Chen TY; Jia KK; Kang LL; Jiao RQ; Kong LD
Redox Biol; 2018 Sep; 18():124-137. PubMed ID: 30014902
[TBL] [Abstract][Full Text] [Related]
4. Polydatin alleviated alcoholic liver injury in zebrafish larvae through ameliorating lipid metabolism and oxidative stress.
Lai Y; Zhou C; Huang P; Dong Z; Mo C; Xie L; Lin H; Zhou Z; Deng G; Liu Y; Chen Y; Huang S; Wu Z; Sun X; Gao L; Lv Z
J Pharmacol Sci; 2018 Sep; 138(1):46-53. PubMed ID: 30245287
[TBL] [Abstract][Full Text] [Related]
5. Nutraceutical therapies for atherosclerosis.
Moss JW; Ramji DP
Nat Rev Cardiol; 2016 Sep; 13(9):513-32. PubMed ID: 27383080
[TBL] [Abstract][Full Text] [Related]
6. Inflammation and atherosclerosis: what is on the horizon?
Ruparelia N; Choudhury R
Heart; 2020 Jan; 106(1):80-85. PubMed ID: 31843811
[No Abstract] [Full Text] [Related]
7. The Utility of Anti-Inflammatory Agents in Cardiovascular Disease: A Novel Perspective on the Treatment of Atherosclerosis.
Kottoor SJ; Arora RR
J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):483-493. PubMed ID: 29783850
[TBL] [Abstract][Full Text] [Related]
8. Targeting the immune response in atherosclerosis: It's time for clinical trials!
Joffre J; Ait-Oufella H
Arch Cardiovasc Dis; 2017 Dec; 110(12):643-645. PubMed ID: 29051009
[No Abstract] [Full Text] [Related]
9. The Characteristics and Roles of Advanced Oxidation Protein Products in Atherosclerosis.
Ou H; Huang Z; Mo Z; Xiao J
Cardiovasc Toxicol; 2017 Jan; 17(1):1-12. PubMed ID: 27350146
[TBL] [Abstract][Full Text] [Related]
10. The potential applications of mushrooms against some facets of atherosclerosis: A review.
Amirullah NA; Zainal Abidin N; Abdullah N
Food Res Int; 2018 Mar; 105():517-536. PubMed ID: 29433243
[TBL] [Abstract][Full Text] [Related]
11. Polydatin attenuates atherosclerosis in apolipoprotein E-deficient mice: Role of reverse cholesterol transport.
Peng Y; Xu J; Zeng Y; Chen L; Xu XL
Phytomedicine; 2019 Sep; 62():152935. PubMed ID: 31085374
[TBL] [Abstract][Full Text] [Related]
12. Exploring immune checkpoints as potential therapeutic targets in atherosclerosis.
Kusters PJH; Lutgens E; Seijkens TTP
Cardiovasc Res; 2018 Mar; 114(3):368-377. PubMed ID: 29309533
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in therapeutic targeting of inflammation in atherosclerosis.
Hedin U; Matic LP
J Vasc Surg; 2019 Mar; 69(3):944-951. PubMed ID: 30591299
[TBL] [Abstract][Full Text] [Related]
14. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions.
Raggi P; Genest J; Giles JT; Rayner KJ; Dwivedi G; Beanlands RS; Gupta M
Atherosclerosis; 2018 Sep; 276():98-108. PubMed ID: 30055326
[TBL] [Abstract][Full Text] [Related]
15. Comparative studies of polydatin and resveratrol on mutual transformation and antioxidative effect in vivo.
Wang HL; Gao JP; Han YL; Xu X; Wu R; Gao Y; Cui XH
Phytomedicine; 2015 May; 22(5):553-9. PubMed ID: 25981921
[TBL] [Abstract][Full Text] [Related]
16. Glucose-6-phosphate dehydrogenase inhibitor for treatment of severe COVID-19: Polydatin.
Doustimotlagh AH; Eftekhari M
Clin Nutr ESPEN; 2021 Jun; 43():197-199. PubMed ID: 34024514
[TBL] [Abstract][Full Text] [Related]
17. Atherosclerosis is a major human killer and non-resolving inflammation is a prime suspect.
Fredman G; MacNamara KC
Cardiovasc Res; 2021 Nov; 117(13):2563-2574. PubMed ID: 34609505
[TBL] [Abstract][Full Text] [Related]
18. Polydatin attenuates spinal cord injury in rats by inhibiting oxidative stress and microglia apoptosis via Nrf2/HO-1 pathway.
Lv R; Du L; Zhang L; Zhang Z
Life Sci; 2019 Jan; 217():119-127. PubMed ID: 30481506
[TBL] [Abstract][Full Text] [Related]
19. Polydatin Attenuates Atherosclerosis in ApoE
Huang Z; Tian G; Cheng S; Zhao D; Zhang Y; Jia Y; Zhou F
Am J Chin Med; 2018; 46(8):1841-1859. PubMed ID: 30537866
[TBL] [Abstract][Full Text] [Related]
20. Lipid-lowering effects of polydatin from Polygonum cuspidatum in hyperlipidemic hamsters.
Du J; Sun LN; Xing WW; Huang BK; Jia M; Wu JZ; Zhang H; Qin LP
Phytomedicine; 2009 Jun; 16(6-7):652-8. PubMed ID: 19106037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
